Westpac Banking Corp increased its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 17.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 135,856 shares of the pharmacy operator’s stock after buying an additional 20,506 shares during the quarter. Westpac Banking Corp’s holdings in Walgreens Boots Alliance were worth $7,427,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently added to or reduced their stakes in WBA. Horan Capital Advisors LLC. acquired a new position in shares of Walgreens Boots Alliance in the first quarter valued at approximately $25,000. Nelson Roberts Investment Advisors LLC bought a new stake in Walgreens Boots Alliance in the first quarter valued at approximately $25,000. Meridian Wealth Management LLC bought a new stake in Walgreens Boots Alliance in the first quarter valued at approximately $25,000. Weaver Consulting Group bought a new stake in Walgreens Boots Alliance in the first quarter valued at approximately $27,000. Finally, Sageworth Trust Co bought a new stake in Walgreens Boots Alliance in the second quarter valued at approximately $27,000. 61.97% of the stock is owned by institutional investors.

Shares of WBA traded down $0.46 during trading hours on Thursday, reaching $49.95. The stock had a trading volume of 1,470,389 shares, compared to its average volume of 4,389,901. Walgreens Boots Alliance Inc has a 12 month low of $49.31 and a 12 month high of $86.31. The stock’s 50-day moving average is $54.33. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37. The firm has a market cap of $46.96 billion, a P/E ratio of 8.30, a price-to-earnings-growth ratio of 1.30 and a beta of 0.81.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.42 by $0.05. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The company had revenue of $34.59 billion for the quarter, compared to analysts’ expectations of $34.52 billion. During the same period last year, the business earned $1.53 EPS. Walgreens Boots Alliance’s quarterly revenue was up .7% compared to the same quarter last year. Sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.99 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Investors of record on Tuesday, August 20th will be issued a $0.458 dividend. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. This represents a $1.83 dividend on an annualized basis and a dividend yield of 3.67%. The ex-dividend date is Monday, August 19th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 29.24%.

Several brokerages recently commented on WBA. Guggenheim began coverage on Walgreens Boots Alliance in a report on Thursday, April 18th. They issued a “neutral” rating and a $59.00 target price on the stock. BidaskClub cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Monday, June 24th. Zacks Investment Research cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 target price on the stock. in a report on Monday, June 10th. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday, June 28th. Finally, Bank of America reduced their target price on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating on the stock in a report on Monday, June 3rd. Six research analysts have rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $63.82.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Further Reading: How to Profit and Limit Losses With Stop Orders

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.